1-Perhydro-2H-pyran-2-yl-3-[3-(3-piperidylpropanoylamino)phenyl]-1H-indazole-5-carboxamide → 3-[3-(3-Piperidylpropanoylamino)Phenyl]-1H-Indazole-5-Carboxamide

HRID 1272935Notes

Reaction equation

HRID 1272935 reaction equation
O1CCCCC1[N:7]1[C:15]2[C:10](=[CH:11][C:12]([C:16]([NH2:18])=[O:17])=[CH:13][CH:14]=2)[C:9]([C:19]2[CH:24]=[CH:23][CH:22]=[C:21]([NH:25][C:26](=[O:35])[CH2:27][CH2:28][CH:29]3[CH2:34][CH2:33][CH2:32][NH:31][CH2:30]3)[CH:20]=2)=[N:8]1>C1(C)C=CC=CC=1>[NH:31]1[CH2:32][CH2:33][CH2:34][CH:29]([CH2:28][CH2:27][C:26]([NH:25][C:21]2[CH:20]=[C:19]([C:9]3[C:10]4[C:15](=[CH:14][CH:13]=[C:12]([C:16]([NH2:18])=[O:17])[CH:11]=4)[NH:7][N:8]=3)[CH:24]=[CH:23][CH:22]=2)=[O:35])[CH2:30]1

Participants

3

Procedure

1-Perhydro-2H-pyran-2-yl-3-[3-(3-piperidylpropanoylamino)phenyl]-1H-indazole-5-carboxamide was suspended in 20 mL of toluene and HCl gas was bubbled through for 15 min. The reaction mixture became gummy and was stirred at room temperature overnight. The supernatant solution was decanted and the residue was purified by preparatory HPLC. (0.017 g, 7% yield over 2 steps): 1H NMR (DMSO d6) δ 13.48 (s, 1H), 10.38 (s, 1H), 8.62 (s, 1H), 8.1 (s, 1H), 7.94 (dd, 1H), 7.94 (dd, 1H), 7.73 (d, 1H), 7.62 (d, 1H), 7.48 (t, 1H), 7.36 (br s, 1H), 2.65 (m, 2H), 2.5 (m, 2H), 2.4 (br s, 4H), 1.52 (m, 4H), 1.40 (m, 2H); ES-MS (m/z) 392 [M+H]+.

Workup

  1. customHCl gas was bubbled through for 15 min
  2. customThe supernatant solution was decanted
  3. customthe residue was purified by preparatory HPLC

Sources & evidence

ORD record
ord-806c4a6770b441e4b48c641af02cff8b
Source dataset
uspto-grants-2007_04
Patent number
US07208513B2

Reaction notes

Loading…